Skip to main content

Mubadala — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

101
Companies
$15.7B
Total invested
$308.0M
Avg. check
56
Industries
Health Care 7Medical 6Information Technology 6Biotechnology 5Software 5FinTech 3+50 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 101
Paragraf
August 2025

Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.

Advanced Materials · Somersham$55.0M Series C
Anaconda
July 2025

Anaconda is an open-source distribution of the Python and R programming languages for data science that simplifies package management.

Analytics · Austin$150.0M Series C
Tenvie Therapeutics
January 2025

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Biotechnology · South San Francisco$200.0M Series A
Precision Neuroscience
December 2024

Precision Neuroscience is a neural platform that engages in brain-computer interface technology.

Medical · New York$102.0M Series C
Firstvet
June 2024

FirstVet is a digital veterinary platform that provides video consultation services for pet owners.

Medical · Stockholm$21.5M Series C
re:cap
June 2024

re:cap is the Capital OS that seamlessly integrates debt funding, liquidity management, financial operations in one platform.

Financial Services · Berlin$14.5M Series A
Arbol
April 2024

Arbol is a climate risk coverage company that offers solutions to analyze .and mitigate exposure to climate risk.

Agriculture · New York$60.0M Series B
Andalusia Labs
December 2023

Andalusia Labs is building foundational digital infrastructure, optimized for internet markets.

Blockchain · San Francisco$48.0M Series A
Orca Bio
January 2026

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Health Care · Menlo Park$250.0M Series F
Light Horse Therapeutics
January 2025

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology · San Diego$62.0M Series A
IXcellerate
January 2022

IXcellerate is an carrier neutral datacentre operator in Moscow that offers pure-play co-location.

Data Center · Moscow$190.0M Series C
Paradigm
December 2025

Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.

Health Care · New York$78.0M Series B
Zelis
December 2024

Zelis is modernizing the healthcare financial experience for all.

Finance · BedminsterPrivate Equity
ACX
December 2022

Where Sustainability Meets the Global Economy

Financial Exchanges · Singapore$15.0M Convertible Note
Rezolv Energy
December 2025

Rezolv Energy develops, owns, and operates renewable power generation assets focused on large-scale wind and solar projects.

Energy · Prague$352.9M Private Equity
Upstream Health
December 2022

Upstream Health provides technologies and new service approaches for health and social care teams.

Fitness · Scunthorpe$140.0M Series B
EQRx
December 2021

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Biotechnology · Cambridge$1.2B Post-IPO Equity
L Nutra
January 2026

L-Nutra is a biotech company that develops life science and nutrition products.

Chemical Engineering · Los Angeles$36.5M Series D
UpStream Care
December 2022

UpStream Care is the ideal marketplace solution for medicine.

Health Care · Greensboro$140.0M Series B
nChroma Bio
December 2024

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Biotechnology · Boston$75.0M Venture - Series Unknown
Huboo
November 2024

Huboo is an eCommerce fulfilment partner using great people and smart technology to enable businesses to grow.

E-Commerce · Bristol$58.3M Undisclosed
HiveMQ
January 2025

HiveMQ is the proven enterprise MQTT platform designed to connect, communicate, and control IoT data under real-world stress.

Enterprise Software · LandshutVenture - Series Unknown
Juvena Therapeutics
January 2026

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

Biopharma · Palo Alto$33.5M Series B
Virtuoso
November 2021

Virtuoso is a software development company that develops codeless test automation software.

Information Services · London$13.3M Series A

Where Mubadala invests

Health Care7
Medical6
Information Technology6
Biotechnology5
Software5
FinTech3

About Mubadala's portfolio

How many companies has Mubadala invested in?

Mubadala has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Mubadala invest in?

Mubadala's top investment sectors include Health Care, Medical, Information Technology, Biotechnology, Software. The firm invests across 56 different industry categories.

What is Mubadala's largest investment?

Among tracked funding rounds, EQRx received $1.2B in a Post-IPO Equity round. Mubadala's total known invested capital is $15.7B.

What is the average investment size for Mubadala?

Mubadala's average investment size is $308.0M across its portfolio of 101 companies.

What are Mubadala's most recent investments?

Recent Mubadala portfolio additions include Paragraf, Anaconda, Tenvie Therapeutics, Precision Neuroscience, Firstvet. These companies were founded in 2020 or later.

Reach the founders behind these 101 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →